Literature DB >> 17275324

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors.

Kensuke Miyake1.   

Abstract

The Toll family of receptors consists of cell surface TLRs (TLR4/MD-2, TLR1, TLR2, and TLR6) and intracellular TLRs (TLR3, TLR7, TLR8, and TLR9). Cell surface TLRs sense microbial membranes such as lipopolysaccharide or lipopeptides. Recognition by TLRs is the frontline where pathogens and a host try to take the control of immune responses. Bacteria can modulate the structure of a TLR ligand lipid A to subvert host responses. Cell surface TLRs also sense endogenous ligands which are released in tissue damages as danger signals and induce inflammation in infectious and non-infectious condition. The availability of endogenous ligands and the amount of cell surface TLRs are both tightly limited to keep TLR responses sufficient for containment of pathogens without detrimental responses to the host.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275324     DOI: 10.1016/j.smim.2006.12.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  187 in total

1.  A synthetic lipid A mimetic modulates human TLR4 activity.

Authors:  Matteo Piazza; Valentina Calabrese; Gaetana Damore; Roberto Cighetti; Theresa Gioannini; Jerrold Weiss; Francesco Peri
Journal:  ChemMedChem       Date:  2011-12-02       Impact factor: 3.466

2.  TLR-mediated innate immune recognition.

Authors:  Ruslan Medzhitov
Journal:  Semin Immunol       Date:  2007-02       Impact factor: 11.130

Review 3.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

4.  Immune response against Sporothrix schenckii in TLR-4-deficient mice.

Authors:  Micheli Fernanda Sassá; Lucas Souza Ferreira; Livia Carolina de Abreu Ribeiro; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

5.  Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation.

Authors:  I Tamayo; J M Irache; C Mansilla; J Ochoa-Repáraz; J J Lasarte; C Gamazo
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

Review 6.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

7.  Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening.

Authors:  Yue Guan; Katherine Omueti-Ayoade; Sarita K Mutha; Paul J Hergenrother; Richard I Tapping
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 8.  Regulation of antigen uptake, migration, and lifespan of dendritic cell by Toll-like receptors.

Authors:  Ivan Zanoni; Francesca Granucci
Journal:  J Mol Med (Berl)       Date:  2010-06-18       Impact factor: 4.599

9.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

10.  Effect of pioglitazone on neuropathic pain and spinal expression of TLR-4 and cytokines.

Authors:  Hongbin Jia; Shuangshuang Xu; Qingzhen Liu; Jian Liu; Jianguo Xu; Weiyan Li; Yi Jin; Qing Ji
Journal:  Exp Ther Med       Date:  2016-09-01       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.